(Q22075876)

Fibrinogen Concentrate (Human) (English)

publication date

17 November 2015

parenteral route of administration

28 February 2017

5.0 gram

route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=B02BB01

active ingredient in

Evarrest

1 reference

European Medicines Agency product number

EMEA/H/C/002515

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002515/human_med_001675.jsp

European Medicines Agency product number

22 March 2017

Raplixa

1 reference

EMEA/H/C/002807

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002807/human_med_001854.jsp

22 March 2017

0 references

1 reference

Fibrinogen Concentrate (Human) (English)

DrugBank

language of work or name

17 November 2015

C81126

1 reference

28 February 2017

UNII

N94833051K

Identifiers

CAS Registry Number

9001-32-5

2 references

https://chem.nlm.nih.gov/chemidplus/rn/9001-32-5

28 February 2017

DSSTox substance ID

DTXSID101010863

0 references

EC number

232-598-6

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.029.622

27 December 2018

ECHA Substance Infocard ID

Fibrinogens (English)

quotation

CAS no.: 9001-32-5 (English)

100.029.622

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.029.622

27 December 2018

Fibrinogens (English)

quotation

CAS no.: 9001-32-5 (English)

ATC code

B02BB01

1 reference

Guide to Pharmacology Ligand ID

28 February 2017

UNII

N94833051K

0 references

2 references

language of work or name

English

Fibrinogen Concentrate (Human) (English)

publication date

17 November 2015

https://www.drugbank.ca/releases/latest#open-data

April 2018

1 reference